Summary & Overview
CPT 83632: Human Placental Lactogen (hPL) Assay
CPT code 83632 reports a laboratory assay measuring human placental lactogen (hPL) in serum to assess placental function during pregnancy. Nationally, this code represents a specialized prenatal laboratory service used in selected clinical scenarios where evaluation of placental hormone production informs clinical decision-making. Use of 83632 is typically limited to obstetric and maternal-fetal medicine practices, hospital laboratories, and reference laboratories equipped for quantitative hormone assays.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for hPL testing, typical sites of service, and payer coverage patterns. The publication summarizes common billing considerations, typical modifiers encountered in claims (input provided), and where available, national benchmarks for utilization and reimbursement. Policy updates and documentation requirements that commonly affect laboratory coding and medical necessity review for specialty prenatal tests are described.
This resource is intended to inform revenue cycle staff, laboratory billing teams, and clinical managers about the clinical purpose of CPT code 83632, common operational settings where the test is ordered, and the payer landscape relevant to national billing and coverage discussions.
Billing Code Overview
CPT code 83632 describes a laboratory measurement of human placental lactogen (hPL), typically performed on a serum specimen. The test is used by clinicians to assess placental function during pregnancy, aiding evaluation of fetal and maternal well-being when placental dysfunction is a concern.
Service type: Laboratory test — quantitative hormone assay
Typical site of service: Clinical laboratory or hospital laboratory (specimen collected in outpatient or inpatient settings depending on clinical need)
Clinical & Coding Specifications
Clinical Context
A 32-year-old pregnant patient at 28 weeks’ gestation presents for evaluation of suspected placental insufficiency due to new-onset fetal growth restriction and declining maternal glucose control. The obstetrician orders a serum human placental lactogen (hPL) measurement to assess placental endocrine function as part of a broader maternal-fetal assessment. The patient has a routine phlebotomy encounter in an outpatient obstetrics clinic; a serum specimen is collected, labeled, and sent to the hospital clinical laboratory. The laboratory analyst performs 83632 to quantify hPL concentration. Results are entered into the electronic medical record and reviewed by the obstetric provider to inform decisions about fetal surveillance intensity, timing of delivery, and need for additional testing such as ultrasound biometry or nonstress testing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional component interpretation of the laboratory result if separated billing applies. |
TC | Technical component |